8-K: Oxbridge Re Subsidiary Launches Digital Token Offering

Oxbridge Re Holdings Limited's subsidiary, SurancePlus Inc., announced the commencement of an offering of Participation Shares represented by digital tokens to fund collateralized reinsurance contracts.

Summary

• Oxbridge Re Holdings Limited and its indirect wholly-owned subsidiary SurancePlus Inc. announced the commencement of an offering of Participation Shares.
• The Participation Shares are represented by digital tokens (T20-2027 for balanced yield and T42-2027 for high yield) and are issued under a 3-year Participation Share Investment Contract (PSIC).
• These Participation Shares are not equity in SurancePlus or Oxbridge Re and solely confer contractual rights against SurancePlus.
• Initially, up to 2,000,000 Participation Shares will be issued at an initial price of $10.00 per share, with varying discounts up to 5% for larger investments.
• Net proceeds from the offering will be used by SurancePlus to purchase participating notes from Oxbridge Re NS, an affiliated Cayman Islands licensed reinsurance entity.
• The proceeds from the sale of these participating notes will be invested in collateralized reinsurance contracts underwritten by Oxbridge Re NS.
• Holders of Participation Shares are entitled to an Investor Final Return, comprising the initial price plus an allocated share of net underwriting profits.
• Profit allocation is subject to preferred return hurdles: 8% (annualized) for balanced yield shares and 16% (annualized) for high yield shares.
• Below the hurdles, 100% of profits are allocated to investors; above the hurdles, profits are generally shared 80% to investors and 20% to SurancePlus.
• The Securities are unregistered and will be sold to accredited investors in the U.S. under SEC Rule 506(c) and to non-U.S. persons under Regulation S.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, indicating an innovative approach to capital formation and expansion into new investment vehicles, though tempered by the inherent risks of unregistered securities and the 'no assurance' clause.

Positives

• The offering provides a new mechanism for SurancePlus to raise capital, potentially funding growth in collateralized reinsurance contracts.
• Introduction of an innovative investment vehicle (digital tokens) that allows investors to participate in reinsurance underwriting profits.
• The structured profit-sharing model with preferred return hurdles offers a clear potential return profile for investors in the Participation Shares.

Negatives

• There is no assurance that the offering of Securities will be completed, introducing uncertainty regarding capital raise success.
• Participation Shares are not equity and do not confer preemptive or conversion rights, limiting investor ownership and control to contractual terms.
• The Securities are unregistered, which restricts their marketability and liquidity to specific investor categories (accredited investors and non-U.S. persons).

Risks

• There can be no assurance that the offering of Securities will be completed.
• The Securities have not been registered under the Securities Act of 1933 or any state or other securities laws, limiting their sale to specific exemptions.
• Forward-looking statements in the report are subject to risks, uncertainties, and assumptions, and actual results could differ materially.
• General risks are discussed under the caption 'Risk Factors' in the company's Form 10-K filed on March 26, 2025, as may be updated.

Future Outlook

The company intends to issue additional Participation Shares in subsequent years (2027 and 2028), with the quantities to be disclosed prior to their issuances. The net proceeds from the current offering are intended to fund investments in collateralized reinsurance contracts.

Management Comments

• Oxbridge Re Holdings Limited and its indirect wholly owned subsidiary SurancePlus Inc. announced the commencement of an offering by SurancePlus of Participation Shares.

Industry Context

StockSavvy.ai notes this offering represents a strategic move by Oxbridge Re into alternative financing and tokenized securities, leveraging its reinsurance expertise. This aligns with a broader industry trend of financial innovation seeking to democratize access to traditionally institutional asset classes and potentially lower capital costs for specialized insurance vehicles. It also highlights the growing intersection of blockchain technology and traditional finance, particularly in niche markets like reinsurance.

Related Party Transactions

• SurancePlus Inc. is an indirect wholly-owned subsidiary of Oxbridge Re Holdings Limited.
• SurancePlus will use net proceeds to purchase participating notes from Oxbridge Re NS, which is an affiliated Cayman Islands licensed reinsurance entity.

Stakeholder Impact

• Shareholders: Potential for increased capital for reinsurance operations, which could lead to future revenue growth, but also potential dilution if the offering is seen as an alternative to equity raises.
• Investors (in Participation Shares): Opportunity to participate in reinsurance underwriting profits with a structured return profile, but subject to contractual terms and unregistered security limitations.
• SurancePlus: Gains access to capital to fund its operations and investments in reinsurance.
• Oxbridge Re NS: Receives proceeds from participating notes to invest in collateralized reinsurance contracts.

Next Steps

• SurancePlus will issue additional Participation Shares in 2027 and 2028, with quantities to be disclosed prior to their issuances.
• SurancePlus will use the net proceeds from the offering to purchase participating notes of Oxbridge Re NS.
• Oxbridge Re NS will invest the proceeds from the sale of such participating notes in collateralized reinsurance contracts.

Key Dates

Recommendation

The offering represents an innovative strategy for capital formation and expansion into the reinsurance market. While it introduces a new revenue stream and investment vehicle, the 'no assurance' clause regarding the completion of the offering and the unregistered nature of the securities introduce uncertainty. Investors should monitor the success of this offering and its impact on Oxbridge Re's overall financial health and risk profile before making significant investment decisions.

Keywords

Oxbridge Re, SurancePlus, digital tokens, Participation Shares, reinsurance, collateralized reinsurance, capital raise, Reg S, Rule 506(c), accredited investors, alternative investments, insurtech